Fig. 3From: MRI-based random survival Forest model improves prediction of progression-free survival to induction chemotherapy plus concurrent Chemoradiotherapy in Locoregionally Advanced nasopharyngeal carcinomaROC curve of each model in the training cohort. Note: A ROC curve of clinical Cox model; B ROC curve of radiomics Cox model; C ROC curve of clinical + radiomics Cox model; D ROC curve of clinical + radiomics RSF modelBack to article page